Index Rebal/Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal/Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

<ul>
<li>A new selection methodology will be used for the ASX index family starting from the September 2025 index review. We first wrote about this a couple of months ago (<a href="https://www.smartkarma.com/insights/quiddity-leaderboard-asx-sep25-update-with-new-important-market-consultation-implications" target="_blank" rel="noopener">link</a>).</li>
<li>In this insight, we present our final expectations for ASX 300, 200, 100, 50, and 20 for the September 2025 index rebal event.</li>
<li>We expect one change for ASX 50, three changes for ASX 100, and six changes for ASX 200. Separately, we see 14 ADDs and 11 DELs for ASX 300.</li>
</ul>


A new selection methodology will be used for the ASX index family starting from the September 2025 index review. We first wrote about this a couple of months ago (link).
In this insight, we present our final expectations for ASX 300, 200, 100, 50, and 20 for the September 2025 index rebal event.
We expect one change for ASX 50, three changes for ASX 100, and six changes for ASX 200. Separately, we see 14 ADDs and 11 DELs for ASX 300.


Quiddity Leaderboard ASX Sep25: Methodology Change Confirmed; Good Performance; Final Expectations

United States

Nexalin Technology, Inc. operates as a medical device company. The Company designs and develops an easy-to-administer medical device that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Nexalin Technology serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Nexalin Technology (NXL US)

Quiddity Leaderboard ASX Sep25: Methodology Change Confirmed; Good Performance; Final Expectations

We have revised our final expectations for the September 2025 index review due to the deletion of Adriatic Metals which was one of our expected...

Janaghan Jeyakumar, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)